Cargando…
Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment /
This book focuses on mAbs targeting EGFR and HER2 and, in five chapters, summarizes information on the use of these mAbs in colorectal cancer, breast cancer, lung cancer, genitourinary cancers, tumors of the skin, the CNS and the head and neck, and gynecologic malignancies.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London, England :
Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK),
©2013.
|
| Colección: | Future Science Group eBook collection,
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn851776810 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m eo d | ||
| 007 | cr cn||||m|||a | ||
| 008 | 130705s2013 enka ob 001 0 eng d | ||
| 040 | |a J2I |b eng |c J2I |d J2I |d OCLCO |d NLGGC |d OCLCQ |d OCLCO |d OCLCF |d OCLCO |d OCLCQ |d OCLCO |d CHVBK |d OCLCQ |d EBLCP |d NLE |d CASUM |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d MM9 |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCL | ||
| 020 | |a 9781780843278 |q (eISBN) | ||
| 020 | |a 1780843275 |q (eISBN) | ||
| 020 | |a 9781780843285 |q (ePub) | ||
| 020 | |a 1780843283 |q (ePub) | ||
| 020 | |z 9781780843292 |q (print) | ||
| 024 | 7 | |a 10.2217/9781780843278 |2 doi | |
| 029 | 1 | |a CHBIS |b 010678186 | |
| 029 | 1 | |a CHVBK |b 364093595 | |
| 035 | |a (OCoLC)851776810 | ||
| 050 | 4 | |a RC271.R26 |b M663 2013eb | |
| 060 | 4 | |a QZ 267 |b M663 2013eb | |
| 082 | 0 | 4 | |a 616.99/40642 |2 22 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / |c editor, Jan B. Vermorken. |
| 260 | |a London, England : |b Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK), |c ©2013. | ||
| 300 | |a 1 electronic text (107 pages) : |b color illustrations, digital file. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a The Future Science Group eBook collection, |x 2047-332X | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Jan B. Vermorken -- Colorectal cancer / Christian Rolfo, Giuseppe Bronte, Antonio Russo & Marc Peeters -- Breast cancer / Sevilay Altintas -- Lung cancer and genitourinary cancers / Dirk Schrijvers -- Tumors of the skin, the CNS and the head and neck / Pol Specenier -- Gynecologic cancers / Jan B. Vermorken -- Index. | |
| 506 | |a Restricted to subscribers or individual electronic text purchasers. | ||
| 530 | |a Also available in print. | ||
| 500 | |a Title from PDF title page (Future Medicine eBooks Web site, viewed June 28, 2013). | ||
| 520 | |a This book focuses on mAbs targeting EGFR and HER2 and, in five chapters, summarizes information on the use of these mAbs in colorectal cancer, breast cancer, lung cancer, genitourinary cancers, tumors of the skin, the CNS and the head and neck, and gynecologic malignancies. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Monoclonal antibodies |x Therapeutic use. | |
| 650 | 0 | |a HER-2 gene. | |
| 650 | 0 | |a HER-2 protein. | |
| 650 | 0 | |a Epidermal growth factor. | |
| 650 | 0 | |a Cancer |x Chemotherapy. | |
| 650 | 1 | 2 | |a Antibodies, Monoclonal |x therapeutic use |
| 650 | 1 | 2 | |a ErbB Receptors |
| 650 | 1 | 2 | |a Neoplasms |x drug therapy |
| 650 | 1 | 2 | |a Receptor, ErbB-2 |
| 650 | 2 | |a Genes, erbB-2 | |
| 650 | 2 | |a Epidermal Growth Factor | |
| 650 | 6 | |a Anticorps monoclonaux |x Emploi en thérapeutique. | |
| 650 | 6 | |a Gène HR2. | |
| 650 | 6 | |a Facteur de croissance épidermique. | |
| 650 | 6 | |a Cancer |x Chimiothérapie. | |
| 650 | 7 | |a Cancer |x Chemotherapy |2 fast | |
| 650 | 7 | |a Epidermal growth factor |2 fast | |
| 650 | 7 | |a HER-2 gene |2 fast | |
| 650 | 7 | |a HER-2 protein |2 fast | |
| 650 | 7 | |a Monoclonal antibodies |x Therapeutic use |2 fast | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Vermorken, Jan B. | |
| 710 | 2 | |a Future Medicine Ltd. | |
| 758 | |i has work: |a Monoclonal Antibodies Targeting EGFR/HER2 and Clinical Outcomes in Cancer Treatment (Text) |1 https://id.oclc.org/worldcat/entity/E39PD3GmcddYvqyq4bkJDcTpdP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |z 9781780843292 |
| 830 | 0 | |a Future Science Group eBook collection, |x 2047-332X | |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5092475 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL5092475 | ||
| 994 | |a 92 |b IZTAP | ||